Howard Rind is a resilient scientist with over 20 years of experience in biopharma research and development, currently serving as the Study Director and Principal Research Scientist in Ophthalmology at Charles River Laboratories. Rind's expertise includes designing and directing preclinical studies for novel therapeutics targeting ocular, neurodegenerative, and metabolic diseases. Past roles include Senior Professional Scientist at Allergan, where they developed neuroprotection test systems, and Senior Scientist at Ceregene, where Rind advanced gene-based therapies for retinal diseases. They are currently pursuing a Ph.D. in Neuroscience at the University of Miami while holding a BS in Biology/Psychology.
Location
Kalamazoo, United States
This person is not in the org chart
This person is not in any offices